Predictors of psychosis remission in psychotic disorders that co-occur with substance use
- PMID: 16873441
- PMCID: PMC2632269
- DOI: 10.1093/schbul/sbl007
Predictors of psychosis remission in psychotic disorders that co-occur with substance use
Abstract
Objective: To examine rates and predictors of psychosis remission at 1-year follow-up for emergency admissions diagnosed with primary psychotic disorders and substance-induced psychoses.
Method: A total of 319 patients with comorbid psychosis and substance use, representing 83% of the original referred sample, were rediagnosed at 1 year postintake employing a research diagnostic assessment. Remission of psychosis was defined as the absence of positive and negative symptoms for at least 6 months. Likelihood ratio chi-square tests and multivariate logistic regression were the main means of analysis.
Results: Of those with a baseline diagnosis of primary psychotic disorder, 50% were in remission at 1 year postintake, while of those with a baseline diagnosis of substance-induced psychosis, 77% were in remission at this time point. Lower Positive and Negative Syndrome Scale (PANSS) symptom levels at baseline, better premorbid functioning, greater insight into psychosis, and a shorter duration of untreated psychosis predicted remission at 1 year in both diagnostic groups. No interaction effects of baseline predictors and diagnosis type were observed. A stepwise multivariate logistic regression holding baseline diagnosis constant revealed the duration of untreated psychosis (odds ratio [OR] = 0.97; 95% confidence interval [CI] = 0.95, 0.997), total PANSS score (OR = 0.98; 95% CI = 0.97, 0.987), Premorbid Adjustment Scale score (OR = 0.13; 95% CI = 0.02, 0.88), and Scale to Assess Unawareness of Mental Disorders unawareness score (OR = 0.84; 95% CI = 0.71, 0.993) as key predictors of psychosis remission.
Conclusions: The association of better premorbid adjustment, a shorter duration of untreated psychosis, better insight into psychotic symptoms, and lower severity of psychotic symptoms with improved clinical outcome, reported previously in studies of schizophrenia, generalizes to psychosis remission in psychotic disorders that are substance induced.
Comment in
-
Current research on co-occurring substance-use disorder in schizophrenia.Schizophr Bull. 2006 Oct;32(4):616-7. doi: 10.1093/schbul/sbl020. Epub 2006 Aug 8. Schizophr Bull. 2006. PMID: 16896056 Free PMC article. No abstract available.
-
Remission one year after emergency admission is higher for substance-induced psychosis than primary psychosis.Evid Based Ment Health. 2007 May;10(2):41. doi: 10.1136/ebmh.10.2.41. Evid Based Ment Health. 2007. PMID: 17459972 No abstract available.
Similar articles
-
Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.Nord J Psychiatry. 2004;58(3):237-42. doi: 10.1080/08039480410006296. Nord J Psychiatry. 2004. PMID: 15204212
-
Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses.Arch Gen Psychiatry. 2005 Feb;62(2):137-45. doi: 10.1001/archpsyc.62.2.137. Arch Gen Psychiatry. 2005. PMID: 15699290
-
The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis.J Clin Psychiatry. 2014 Jun;75(6):e566-72. doi: 10.4088/JCP.13m08606. J Clin Psychiatry. 2014. PMID: 25004197
-
[Epidemiology, etiology and treatment of patients with psychosis and co-morbid substance use disorder].Ther Umsch. 2018 Jun;75(1):37-43. doi: 10.1024/0040-5930/a000964. Ther Umsch. 2018. PMID: 29909760 Review. German.
-
Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Harv Rev Psychiatry. 2009. PMID: 19205964 Review.
Cited by
-
Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study.Int J Ment Health Syst. 2021 May 6;15(1):42. doi: 10.1186/s13033-021-00464-0. Int J Ment Health Syst. 2021. PMID: 33957944 Free PMC article.
-
Symptomatic and Functional Remission in Young Adults with a Psychotic Disorder in a Rehabilitation Focused Team.Community Ment Health J. 2020 Apr;56(3):549-558. doi: 10.1007/s10597-019-00512-7. Epub 2019 Dec 9. Community Ment Health J. 2020. PMID: 31820293 Free PMC article.
-
Psychosis Prognosis Predictor: A continuous and uncertainty-aware prediction of treatment outcome in first-episode psychosis.Acta Psychiatr Scand. 2025 Mar;151(3):280-292. doi: 10.1111/acps.13754. Epub 2024 Sep 18. Acta Psychiatr Scand. 2025. PMID: 39293941 Free PMC article.
-
The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.Schizophr Bull. 2017 Jul 1;43(4):843-851. doi: 10.1093/schbul/sbw179. Schizophr Bull. 2017. PMID: 28199703 Free PMC article.
-
Personalized risk assessment of drug-related harm is associated with health outcomes.PLoS One. 2013 Nov 6;8(11):e79754. doi: 10.1371/journal.pone.0079754. eCollection 2013. PLoS One. 2013. PMID: 24223192 Free PMC article.
References
-
- Strakowski SM, McElroy SL, Keck PE, West SA. The effects of antecedent substance abuse on the development of first-episode psychotic mania. J Psychiatr Res. 1996;30:59–68. - PubMed
-
- Kessler RC. Epidemiology of psychiatric comorbidity. In: Tsuang MT, Tohen M, Zahner GEP, editors. Textbook of Psychiatric Epidemiology. New York, NY: Wiley-Liss; 1995. pp. 179–197.
-
- Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 1990;264:2511–2518. - PubMed
-
- Negrete JC. Clinical aspects of substance abuse in persons with schizophrenia. Can J Psychiatry. 2003;48:14–21. - PubMed
-
- Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the Study of Low Prevalence Disorders. Aust N Z J Psychiatry. 2000;34:221–236. - PubMed